Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical device
inhaler |
| gptkbp:activeIngredient |
gptkb:aclidinium
|
| gptkbp:alternativeName |
gptkb:Genuair_inhaler
Tudorza Pressair |
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:brand |
gptkb:aclidinium_bromide
|
| gptkbp:form |
dry powder inhaler
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pressair inhaler
|
| gptkbp:includesDrug |
gptkb:aclidinium_bromide
|
| gptkbp:indication |
maintenance treatment of COPD
|
| gptkbp:manufacturer |
gptkb:AstraZeneca
|
| gptkbp:marketedIn |
gptkb:Europe
gptkb:United_States |
| gptkbp:mechanismOfAction |
muscarinic antagonist
|
| gptkbp:notRecommendedFor |
acute bronchospasm
|
| gptkbp:platform |
breath-actuated inhaler
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
inhalation
|
| gptkbp:usedFor |
asthma
chronic obstructive pulmonary disease |
| gptkbp:bfsParent |
gptkb:Duaklir_Pressair
|
| gptkbp:bfsLayer |
7
|